Sera Prognostics, Inc.

Aug 06, 2025

SERA PROGNOSTICS REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS

Jul 29, 2025

Sera Prognostics Announces Conference Call and Webcast of Second Quarter Fiscal Year 2025 Financial Results on August 6, 2025

May 07, 2025

SERA PROGNOSTICS REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS

Feb 21, 2025

Sera Prognostics To Present at TD Cowen 45th Annual Health Care Conference

Feb 10, 2025

Sera Prognostics Announces Pricing of $50 Million Public Offering

Feb 10, 2025

Sera Prognostics Announces Proposed Public Offering

Dec 02, 2024

Sera Prognostics to Present at Piper Sandler 36th Annual Healthcare Conference

Nov 06, 2024

SERA PROGNOSTICS REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS

Aug 08, 2024

Sera Prognostics to Participate in Panel Discussion at UBS Genomic Medicine Summit on August 14, 2024

Jul 09, 2024

Sera Prognostics PreTRM® Test Prevention Strategy Demonstrates 18% Reduction in Severe Neonatal Morbidity and Mortality in Newly Published AVERT Trial

Jul 01, 2024

SERA PROGNOSTICS ADDED TO RUSSELL 2000 AND 3000 INDEXES FOLLOWING CONCLUSION OF 2024 INDEXES ANNUAL RECONSTITUTION

May 28, 2024

SERA PROGNOSTICS EXPECTED TO BE ADDED TO RUSSELL 2000 AND 3000 INDEXES

Mar 20, 2024

SERA PROGNOSTICS REPORTS FOURTH QUARTER 2023 FINANCIAL RESULTS

Mar 04, 2024

Sera Prognostics Announces Conference Call and Webcast of Fourth Quarter and Fiscal Year 2023 Financial Results on March 20, 2024